<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02534623</url>
  </required_header>
  <id_info>
    <org_study_id>GHZ trial 001</org_study_id>
    <nct_id>NCT02534623</nct_id>
  </id_info>
  <brief_title>Postoperative Quality of Recovery After Transurethral Resection of the Bladder</brief_title>
  <official_title>Postoperative Quality of Recovery After Transurethral Resection of the Bladder: Spinal Versus General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>General Hospital Zadar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>General Hospital Zadar</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transurethral resection of the bladder (TURB) is often performed as an outpatient procedure
      so high-quality postoperative recovery is particularly important. The aim of this study is to
      compare postoperative quality of recovery after spinal anesthesia (SA) and general anesthesia
      (GA) for transurethral resection of the bladder.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After written informed consent is obtained seventy patients aged 18-80 years, ASA (American
      Society of Anesthesiologists) physical status class I-III scheduled for TURB will be randomly
      assigned to either spinal anesthesia or general anesthesia. Spinal anesthesia will be
      performed with 12.5 mg of bupivacaine mixed with 25 mcg of fentanyl. General anesthesia will
      be performed with propofol and fentanyl and maintained with sevoflurane, without use of
      neuromuscular blocking agents. Quality of Recovery 40 questionnaire (QoR-40) administered
      before and 24 hours after surgery will be used for assessment of postoperative recovery.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Recovery 40 (QoR-40)</measure>
    <time_frame>24 hours</time_frame>
    <description>Quality of Recovery 40 questionnaire at 24 hours</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative opioid consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>Postoperative opioid consumption over 24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain measured with visual analogue scale</measure>
    <time_frame>1,6 and 24 hours</time_frame>
    <description>Postoperative pain measured with visual analogue scale at 1,6 and 24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction with anesthesia measured with numerical rating scale</measure>
    <time_frame>24 hours</time_frame>
    <description>Overall patient satisfaction with anesthesia measured with numerical rating scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Urinary Bladder Neoplasms</condition>
  <condition>Transurethral Resection of the Bladder</condition>
  <condition>Postoperative Recovery</condition>
  <arm_group>
    <arm_group_label>Spinal anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transurethral resection of the bladder performed under spinal anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>General anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transurethral resection of the bladder performed under general anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Spinal anesthesia</intervention_name>
    <arm_group_label>Spinal anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>General anesthesia</intervention_name>
    <arm_group_label>General anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine</intervention_name>
    <arm_group_label>Spinal anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fentanyl</intervention_name>
    <arm_group_label>Spinal anesthesia</arm_group_label>
    <arm_group_label>General anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <arm_group_label>General anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane</intervention_name>
    <arm_group_label>General anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Transurethral resection of the bladder

          -  Age 18 to 80 years

          -  ASA I-III

        Exclusion Criteria:

          -  Contraindications for spinal anesthesia

          -  Chronic pain with use of opioids in the last week

          -  Psychiatric disorders

          -  Allergy to medications used in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nina Sulen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>General Hospital Zadar</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>General Hospital Zadar</name>
      <address>
        <city>Zadar</city>
        <zip>23000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nina Sulen, MD</last_name>
      <phone>0038598738734</phone>
      <email>nina.sulen@zd.t-com.hr</email>
    </contact>
    <contact_backup>
      <last_name>Tatjana Simurina, MD, PhD</last_name>
      <phone>0038598331865</phone>
      <email>tatjana.simurina@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Nina Sulen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tatjana Simurina, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tomislav Soric, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <reference>
    <citation>Gornall BF, Myles PS, Smith CL, Burke JA, Leslie K, Pereira MJ, Bost JE, Kluivers KB, Nilsson UG, Tanaka Y, Forbes A. Measurement of quality of recovery using the QoR-40: a quantitative systematic review. Br J Anaesth. 2013 Aug;111(2):161-9. doi: 10.1093/bja/aet014. Epub 2013 Mar 6. Review.</citation>
    <PMID>23471753</PMID>
  </reference>
  <reference>
    <citation>Catro-Alves LJ, De Azevedo VL, De Freitas Braga TF, Goncalves AC, De Oliveira GS Jr. The effect of neuraxial versus general anesthesia techniques on postoperative quality of recovery and analgesia after abdominal hysterectomy: a prospective, randomized, controlled trial. Anesth Analg. 2011 Dec;113(6):1480-6. doi: 10.1213/ANE.0b013e3182334d8b. Epub 2011 Sep 16.</citation>
    <PMID>21926374</PMID>
  </reference>
  <reference>
    <citation>Barbosa FT, Castro AA. Neuraxial anesthesia versus general anesthesia for urological surgery: systematic review. Sao Paulo Med J. 2013;131(3):179-86. Review.</citation>
    <PMID>23903267</PMID>
  </reference>
  <reference>
    <citation>Tyritzis SI, Stravodimos KG, Vasileiou I, Fotopoulou G, Koritsiadis G, Migdalis V, Michalakis A, Constantinides CA. Spinal versus General Anaesthesia in Postoperative Pain Management during Transurethral Procedures. ISRN Urol. 2011;2011:895874. doi: 10.5402/2011/895874. Epub 2011 Jul 12.</citation>
    <PMID>22084807</PMID>
  </reference>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2015</study_first_submitted>
  <study_first_submitted_qc>August 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2015</study_first_posted>
  <last_update_submitted>August 26, 2015</last_update_submitted>
  <last_update_submitted_qc>August 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>General Hospital Zadar</investigator_affiliation>
    <investigator_full_name>Nina Sulen</investigator_full_name>
    <investigator_title>Anesthesiology and Intensive Medicine Specialist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

